Wednesday, August 23, 2017

See Why Catalyst Biosciences (CBIO) Is A Traders Dream Strong Buy

Shares of Catalyst Biosciences Inc (NASDAQ:CBIO) surged from $5.00 to near $19.00 in one trading day. This happened after the company announced exciting new drug developments, especially for a company with a current market cap of $8 million. This micro sized biotech allows for these crazy runs and pull backs. The key for a trader is timing the buying levels with technical chart levels. This brings me to why at current price points, I strongly favor Catalyst Biosciences…

Custom Admissions Essays Writing The stock has fallen from $19 over the last five trading days to $8. This $8 level happens to coincide with the gap window (the price the stock gaped higher by on the drug news). In technical analysis, this is a firm support level. In addition, right below lies the daily 20 and 50 moving averages, also big support levels. In addition, within days the stock will hit a master time count, a key factor known in proprietary price, pattern and time analysis sectors to cause a huge move. There are tons of average investors waiting to chase when the next pop happens. It likely is within a day or two and right around this price point. I am a buyer, looking for a pop to $10.50, maybe higher. Remember, micro cap stocks like this carry a ton of risk so if you decide to buy, go super light on shares.

Gareth Soloway
InTheMoneyStocks1



[[T_F]]Data Leak Prevention – Data Security Solutions – Information Theft Protection, Detection and Prevention Software Productstracefusion_signature=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[[T_F]]



| More

Comments are closed

Back to Top

Social Media Profiles

ADVERTISEMENT

BUSINESS NETWORKS

The New York Times logo CNN logo ABC logo CNBC logo